APRIL THOMPSON: Open Payments
NPI 1881281780 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 50 payments from 15 companies in 2025. Trend: 2023 $524 · 2024 $791 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $282 |
| PFIZER INC. | 10 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| Phathom Pharmaceuticals, Inc. | 2 | $127 |
| Aimmune Therapeutics, Inc. | 5 | $82 |
| GENZYME CORPORATION | 2 | $66 |
| NeurAxis, Inc. | 1 | $58 |
| Madrigal Pharmaceuticals | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Ardelyx, Inc. | 1 | $28 |
Products named: VELSIPITY, VOQUEZNA, RINVOQ, ENTYVIO, ZENPEP, LINZESS, DUPIXENT, SKYRIZI.
Industry payments across FL — which companies pay providers there.
